Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wojnar

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Transplantation Proceedings|December 21, 2002
Autologous hematopoietic stem cell transplantation for high-risk Hodgkin's disease: a single-center experience with the first 100 patientsJ Holowiecki, S Giebel, J Wojnar, et al.
Acta Haematologica Polonica|January 1, 1994
[Results of induction treatment with idarubicin for acute nonlymphoblastic leukemia in adults]J Hołowiecki, S Krzemień, E Rudzka, et al.
Bone Marrow Transplantation|October 26, 2005
Unrelated donor bone marrow transplantation with treosulfan-based myeloablative conditioning for paroxysmal nocturnal hemoglobinuria--successful treatment despite multiple transplant-related risk factors for hemolysis including major Kidd group incompatibilityM Markiewicz, M Wojciechowska, I Wylezoł, et al.
Transplantation Proceedings|December 1, 1996
Autologous bone marrow transplantation in adult acute lymphoblastic leukaemiaJ Wojnar, J Hołowiecki, M Krawczyk-Kuliś, et al.
Transplantation Proceedings|March 1, 2006
Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantationS Giebel, I Nowak, J Wojnar, et al.
Arzneimittel-Forschung|December 1, 1986
Androstene-17-thioketals. 2nd communication: pharmacological profiles of tipredane and (11 beta, 17 alpha)-17-(ethylthio)-9 alpha-fluoro-17-[2-(fluoroethyl)thio]-11 beta-hydroxy-androsta-1,4-dien-3-one, structurally novel 20-thiasteroids possessing potent and selective topical antiinflammatory activityB N Lutsky, R C Millonig, R J Wojnar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1991
Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuitA Bochenek, Z Religa, R Kustosz, et al.
Bone Marrow Transplantation|July 12, 2005
Imatinib therapy prior to myeloablative allogeneic stem cell transplantationJ M Zaucha, W Prejzner, S Giebel, et al.
Bone Marrow Transplantation|February 2, 2010
Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCTS Giebel, J Dziaczkowska, T Czerw, et al.
Journal of Medicinal Chemistry|July 1, 1973
Antiinflammatory activities of 2-acetyl- and 2-(1-hydroxyethyl)-4-(3-(dimethylamino)propyl)-3,4-dihydro-3-phenyl-2H-1,4-benzothiazineR C Millonig, M B Goldlust, W E Maguire, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Transplantation Proceedings|December 21, 2002
Autologous hematopoietic stem cell transplantation for high-risk Hodgkin's disease: a single-center experience with the first 100 patientsJ Holowiecki, S Giebel, J Wojnar, et al.
Acta Haematologica Polonica|January 1, 1994
[Results of induction treatment with idarubicin for acute nonlymphoblastic leukemia in adults]J Hołowiecki, S Krzemień, E Rudzka, et al.
Bone Marrow Transplantation|October 26, 2005
Unrelated donor bone marrow transplantation with treosulfan-based myeloablative conditioning for paroxysmal nocturnal hemoglobinuria--successful treatment despite multiple transplant-related risk factors for hemolysis including major Kidd group incompatibilityM Markiewicz, M Wojciechowska, I Wylezoł, et al.
Transplantation Proceedings|December 1, 1996
Autologous bone marrow transplantation in adult acute lymphoblastic leukaemiaJ Wojnar, J Hołowiecki, M Krawczyk-Kuliś, et al.
Transplantation Proceedings|March 1, 2006
Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantationS Giebel, I Nowak, J Wojnar, et al.
Arzneimittel-Forschung|December 1, 1986
Androstene-17-thioketals. 2nd communication: pharmacological profiles of tipredane and (11 beta, 17 alpha)-17-(ethylthio)-9 alpha-fluoro-17-[2-(fluoroethyl)thio]-11 beta-hydroxy-androsta-1,4-dien-3-one, structurally novel 20-thiasteroids possessing potent and selective topical antiinflammatory activityB N Lutsky, R C Millonig, R J Wojnar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1991
Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuitA Bochenek, Z Religa, R Kustosz, et al.
Bone Marrow Transplantation|July 12, 2005
Imatinib therapy prior to myeloablative allogeneic stem cell transplantationJ M Zaucha, W Prejzner, S Giebel, et al.
Bone Marrow Transplantation|February 2, 2010
Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCTS Giebel, J Dziaczkowska, T Czerw, et al.
Journal of Medicinal Chemistry|July 1, 1973
Antiinflammatory activities of 2-acetyl- and 2-(1-hydroxyethyl)-4-(3-(dimethylamino)propyl)-3,4-dihydro-3-phenyl-2H-1,4-benzothiazineR C Millonig, M B Goldlust, W E Maguire, et al.
Pageof 7